George taps Medisante tech for decentralised blood pressure trial
pharmaphorum
SEPTEMBER 16, 2022
“Telemedicine is the leading decentralisation approach in clinical trials today and one that can help us to improve how we study the effects of our medicines on patients,” commented Stefan König, chief executive of George Medicines. By 2030, it is projected that over 215 million Africans will have hypertension.
Let's personalize your content